Lataa...

Engineering Chimeric Antigen Receptor T cells to Treat Glioblastoma

Immunotherapy has emerged as a promising strategy for glioblastoma (GBM), a disease that remains universally fatal despite currently available standard-of-care. Adoptive T cell therapy has been shown to produce potent antitumor immunity while obviating the need for traditional antigen presentation a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Target Ther Cancer
Päätekijät: Choi, Bryan D., O’Rourke, Donald M., Maus, Marcela V.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2017
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5695679/
https://ncbi.nlm.nih.gov/pubmed/29167820
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!